Orthofix Medical Inc.OFIXEarnings & Financial Report
Orthofix Medical Inc. is a global medical device firm specializing in orthopedic care. It develops, manufactures and sells spinal implants, trauma care products, bone growth stimulation therapies and regenerative medicine offerings, serving orthopedic surgeons and healthcare providers across North America, Europe and Asia Pacific.
OFIX Q4 FY2025 Key Financial Metrics
Revenue
$219.9M
Gross Profit
$156.3M
Operating Profit
$494.0K
Net Profit
$-2.2M
Gross Margin
71.1%
Operating Margin
0.2%
Net Margin
-1.0%
YoY Growth
2.0%
EPS
$-0.05
Orthofix Medical Inc. Q4 FY2025 Financial Summary
Orthofix Medical Inc. reported revenue of $219.9M (up 2.0% YoY) for Q4 FY2025, with a net profit of $-2.2M (up 92.4% YoY) (-1.0% margin). Cost of goods sold was $63.6M, operating expenses totaled $155.8M.
Key Financial Metrics
| Total Revenue | $219.9M |
|---|---|
| Net Profit | $-2.2M |
| Gross Margin | 71.1% |
| Operating Margin | 0.2% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Orthofix Medical Inc. Q4 FY2025 revenue of $219.9M breaks down across 7 segments, led by Spinal Implants Biologics And Enabling Technologies at $113.6M (51.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 51.7% |
| Bone Growth Therapies | $68.3M | 31.1% |
| Other | $22.7M | 10.3% |
| IT | $5.9M | 2.7% |
| GB | $3.5M | 1.6% |
| FR | $3.5M | 1.6% |
| DE | $2.3M | 1.1% |
Orthofix Medical Inc. Revenue by Segment — Quarterly Trend
Orthofix Medical Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Spinal Implants Biologics And Enabling Technologies and Bone Growth Therapies) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Spinal Implants Biologics And Enabling Technologies | $113.6M | $110.9M | $107.3M | $108.8M |
| Bone Growth Therapies | $68.3M | $61.2M | — | — |
| Other | $22.7M | $18.1M | $51.5M | $49.1M |
| IT | $5.9M | $5.7M | $5.6M | — |
| GB | $3.5M | $3.6M | — | — |
Orthofix Medical Inc. Annual Revenue by Year
Orthofix Medical Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $822.3M).
Orthofix Medical Inc. Quarterly Revenue & Net Profit History
Orthofix Medical Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $219.9M | +2.0% | $-2.2M | -1.0% |
| Q3 FY2025 | $205.6M | +4.6% | $-22.8M | -11.1% |
| Q2 FY2025 | $203.1M | +2.3% | $-14.1M | -6.9% |
| Q1 FY2025 | $193.6M | +2.7% | $-53.1M | -27.4% |
| Q4 FY2024 | $215.7M | +7.6% | $-29.1M | -13.5% |
| Q3 FY2024 | $196.6M | +6.8% | $-27.4M | -13.9% |
| Q2 FY2024 | $198.6M | +6.2% | $-33.4M | -16.8% |
| Q1 FY2024 | $188.6M | +7.7% | $-36.0M | -19.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $188.6M | $198.6M | $196.6M | $215.7M | $193.6M | $203.1M | $205.6M | $219.9M |
| YoY Growth | 7.7% | 6.2% | 6.8% | 7.6% | 2.7% | 2.3% | 4.6% | 2.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $906.0M | $882.0M | $867.9M | $893.3M | $823.1M | $837.2M | $832.6M | $850.6M |
| Liabilities | $335.7M | $336.0M | $341.9M | $390.2M | $364.9M | $378.8M | $390.1M | $400.6M |
| Equity | $570.3M | $546.0M | $525.9M | $503.1M | $458.3M | $458.3M | $442.5M | $450.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-18.6M | $9.0M | $11.7M | $23.7M | $-18.4M | $11.6M | $12.4M | $27.7M |